Video

Lawrence Friedhoff, MD, PhD, and Ilise Lombardo, MD

Publish date: August 7, 2015

At the 2015 Alzheimer's Association International Conference, Drs. Friedhoff and Lombardo discuss results from the completer analysis of RVT-101 as an adjunct to donepezil in adults with mild to moderate Alzheimer’s disease.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Does Solanezumab Modify Alzheimer's Disease Progression?
MDedge Neurology
VIDEO: Keeping the Alzheimer’s big picture in mind as antiamyloid trials continue
MDedge Neurology
Schizophrenia decreases hippocampal and prefrontal cortex activity
MDedge Neurology
Insulin resistance linked to decreased brain metabolism, memory function
MDedge Neurology
Howard S. Kirshner, MD
MDedge Neurology
AAIC 2015: Approved drug combo cuts Alzheimer’s disease agitation
MDedge Neurology
AAIC: Aerobic exercise proves beneficial for mild cognitive impairment
MDedge Neurology
How Much Sleep Is Required for Peak Cognitive Performance?
MDedge Neurology
Cognitive benefits apparent with commercially available supplement
MDedge Neurology
Rachel Whitmer, PhD
MDedge Neurology

Related Articles